Differential expression and role of hyperglycemia induced oxidative stress in epigenetic regulation of β1, β2 and β3-adrenergic receptors in retinal endothelial cells

BMC Medical Genomics

Volumn 7, Issue 1, 2014, Pages

  Safi, Sher Zaman ^a   Qvist, Rajes ^a   Yan, Gracie Ong Siok ^a   Ismail, Ikram Shah Bin ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Adrenergic receptors; Expression; Methylation; Retinal endothelial cells; ROS

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; MESSENGER RNA; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; BETA 1 ADRENERGIC RECEPTOR GENE; BETA 2 ADRENERGIC RECEPTOR GENE; BETA 3 ADRENERGIC RECEPTOR GENE; CELL ASSAY; CONTROLLED STUDY; CPG ISLAND; DIABETIC RETINOPATHY; DNA DAMAGE; DNA METHYLATION; ENDOTHELIUM CELL; EPIGENETICS; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNOCYTOCHEMISTRY; NICK END LABELING; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR GENE; RETINA CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOPTOSIS; BASE SEQUENCE; CPG ISLANDS; DNA METHYLATION; ENDOTHELIAL CELLS; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GLUCOSE; HUMANS; HYPERGLYCEMIA; MOLECULAR SEQUENCE DATA; OXIDATIVE STRESS; PROMOTER REGIONS, GENETIC; RECEPTORS, ADRENERGIC; RECEPTORS, ADRENERGIC, BETA-1; RETINA;

EID: 84902388496     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-7-29     Document Type: Article

References (56)

1. Mitochondrial protein acylation and intermediary metabolism: regulation by sirtuins and implications for metabolic disease. Newman JC, He W, Verdin E, J Biol Chem 2012 287 42463 42443
2. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Wild S, Roglic G, Green A, Sicree R, King H, Diabetes Care 2004 27 1047 1053 10.2337/diacare.27.5.1047 15111519 (Pubitemid 38579764)
3. World Health Organization, Diabetes Action Now, An initiative of the world health organization and the international diabetes federation Geneva: World Health Organization 2004
4. The prevalence of diabetic retinopathy among adults in the United States. Kempen JH, O'Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, Taylor HR, Hamman RF, Arch Ophthalmol 2004 122 552 563 15078674 (Pubitemid 38456292)
5. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, Girach A, Eye 2004 18 963 983 10.1038/sj.eye.6701476 15232600 (Pubitemid 39430033)
6. Diabetic Retinopathy: Mitochondrial Dysfunction and Retinal Capillary Cell Death. Kowluru RA, Antioxid Redox Signal 2005 7 1581 10.1089/ars.2005.7. 1581 16356121 (Pubitemid 41767993)
7. Therapeutic potential of anti-oxidants and diabetic retinopathy. Kowluru RA, Kennedy A, Expert Opin Investig Drugs 2001 10 1665 1676 10.1517/13543784.10. 9.1665 11772276 (Pubitemid 32830146)
8. Expression of Apoptosis Markers in the Retinas of Human Subjects with Diabetes. El-Asrar AMA, Dralands L, Missotten L, Al-Jadaan IA, Geboes K, Invest Ophthalmol Vis Sci 2004 45 2760 2766 10.1167/iovs.03-1392 15277502 (Pubitemid 38998875)
9. TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations. Joussen AM, Doehmen S, Le ML, Mol Vis 2009 15 1418 1428 19641635
10. Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: a role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway. Cheng X, Siow RC, Mann GE, Antioxid Redox Signal 2011 14 469 487 10.1089/ars.2010.3283 20524845
11. Biochemistry and molecular cell biology of diabetic complications. Brownlee M, Nature 2001 414 813 820 10.1038/414813a 11742414 (Pubitemid 34000785)
12. Epigenetic mechanisms in diabetic vascular complications. Reddy MA, Natarajan R, Cardiovasc Res 2011 90 3 421 429 10.1093/cvr/cvr024 21266525
13. Aberrant DNA methylation in malignant melanoma. Schinke C, Mo Y, Yu Y, Amiri K, Sosman J, Greally J, Verma A, Melanoma Res 2010 20 253 265 10.1097/CMR.0b013e328338a35a 20418788
14. International Union of Pharmacology nomenclature of adrenoceptors. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR Jr, Trendelenburg U, Pharmacol Rev 1994 46 2 121 136 7938162
15. β-adrenergic mechanisms in cardiac diseases: A perspective. Chakraborti S, Chakraborti T, Shaw G, Cell Signal 2000 12 499 513 10.1016/S0898-6568(00)00087-5 11027943
16. β-Adrenergic receptors: biochemical mechanisms of physiological regulation. Stiles GL, Caron MG, Lefkowitz RJ, Physiol Rev 1984 64 661 743 6143332 (Pubitemid 14139089)
17. Similarities and differences in the coupling of human beta1- and beta2-adrenoceptors to Gs(alpha) splice variants. Wenzel-Seifert K, Liu HY, Seifert R, Biochem Pharmacol 2002 64 9 20 10.1016/S0006-2952(02)00924-3 12106601 (Pubitemid 34775171)
18. Functional beta3-adrenoceptor in the human heart. Gauthier C, Tavernier G, Charpentier F, Langin D, Le Marec H, J Clin Invest 1996 98 556 562 10.1172/JCI118823 8755668
19. Beta adrenergic binding sites in the human eye: an autoradiographic study. Elena PP, Denis P, Kosina-Boix M, Saraux H, Lapalus P, J Ocul Pharmacol 1990 6 2 143 149 10.1089/jop.1990.6.143 2168462 (Pubitemid 20299335)
20. Beta-adrenergic receptor stimulation modulates iNOS protein levels through p38 and ERK1/2 signaling in human retinal endothelial cells. Steinle JJ, Chin VC, Williams KP, Panjala SR, Exp Eye Res 2008 87 1 30 34 10.1016/j.exer.2008.04.008 18541234
21. Role of beta-adrenergic receptors in inflammatory marker expression in muller cells. Walker R, Steinle J, Invest Ophthalmol Vis Sci 2007 48 11 5276 5281 10.1167/iovs.07-0129 17962483 (Pubitemid 351260941)
22. Maintenance of beta-adrenergic receptor signaling can reduce Fas signaling in human retinal endothelial cells. Williams KP, Steinle JJ, Exp Eye Res 2009 89 4 448 455 10.1016/j.exer.2009.04.015 19523948
23. Appearance of brown adipocytes in white adipose tissue during CL 316,243-induced reversal of obesity and diabetes in Zucker fa/fa rats. Ghorbani M, Himms-Hagen J, Int J Obes 1997 21 465 475 10.1038/sj.ijo.0800432 (Pubitemid 27236965)
24. Antidiabetic and antiobesity effects of a highly selective ß3-adrenoceptor agonist (CL 316,243). Largis E, Burns M, Muenkel H, Dolan J, Claus T, Drug Dev Res 1994 1994 32 69 76 (Pubitemid 24207174)
25. Systemic propranolol reduces b-wave amplitude in the ERG and increases IGF-1 receptor phosphorylation in rat retina. Jiang Y, Steinle JJ, Invest Ophthalmol Vis Sci 2010 51 5 2730 2735 10.1167/iovs.09-4779 20042659
26. Epigenetics: a molecular link between environmental factors and type 2 diabetes. Ling C, Groop L, Diabetes 2009 58 2718 2725 10.2337/db09-1003 19940235
27. Human DNA methylomes at base resolution show widespread epigenomic differences. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM, Edsall L, Antosiewicz-Bourget J, Stewart R, Ruotti V, Millar AH, Thomson JA, Ren B, Ecker JR, Nature 2009 462 7271 315 322 10.1038/nature08514 19829295
28. Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Ling C, Del Guerra S, Lupi R, Rönn T, Granhall C, Luthman H, Masiello P, Marchetti P, Groop L, Del Prato S, Diabetologia 2008 51 4 615 622 10.1007/s00125-007-0916-5 18270681
29. Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle. Rönn T, Poulsen P, Hansson O, Holmkvist J, Almgren P, Nilsson P, Tuomi T, Isomaa B, Groop L, Vaag A, Ling C, Diabetologia 2008 51 7 1159 1168 10.1007/s00125-008-1018-8 18488190
30. The epigenetic conductor: a genomic orchestrator in chronic kidney disease complications? Ekstrom TJ, Stenvinkel P, J Nephrol 2009 22 442 449 19662598
31. Epigenetics in hyperhomocysteinemic states. A special focus on uremia. Ingrosso D, Perna AF, Biochim Biophys Acta 2009 1790 892 899 10.1016/j.bbagen.2008.11.010 19245874
32. Endogenous expression of adenosine receptors in rat C6 glioma cells. Castillo C, Albasanz J, Fernandez M, Martin M, Neurochem Res 2007 32 1056 1070 10.1007/s11064-006-9273-x 17401671 (Pubitemid 46726027)
33. Role of β-Adrenergic Receptors in Inflammatory Marker Expression in Muller Cells. Walkernand RJ, Steinle JJ, Invest Ophthalmol Vis Sci 2007 160 1 1 40
34. Lipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetes. Averill MM, Bornfeldt KE, Curr Diab Rep 2009 9 18 25 10.1007/s11892-009-0005-x 19192420
35. Microvascular complications of diabetes. He Z, King GL, Endocrinol Metab Clin North Am 2004 33 215 238 10.1016/j.ecl.2003.12.003 15053904 (Pubitemid 38438432)
36. Overview: combating diabetic nephropathy. Ziyadeh FN, Sharma K, J Am Soc Nephrol 2003 14 1355 1357 10.1097/01.ASN.0000065608.37756.58 12707405 (Pubitemid 36514676)
37. Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Ishiyama-Shigemoto S, Yamada K, Yuan X, Ichikawa F, Nonaka K, Diabetologia 1999 42 1 98 101 10.1007/s001250051120 10027586 (Pubitemid 29039745)
38. Deficiency of cardiac beta-adrenergic receptor in streptozocin-induced diabetic rats. Nishio Y, Kashiwagi A, Kida Y, Kodama M, Abe N, Saeki Y, Shigeta Y, Diabetes 1988 37 1181 1187 10.2337/diab.37.9.1181 2842211 (Pubitemid 19035048)
39. Involvement of endothelial cells in relaxation and contraction responses of the aorta to isoproterenol in naive and streptozotocin-induced diabetic rats. Kamata K, Miyata N, Kasuya Y, J Pharmacol Exp Ther 1989 249 890 894 2543815 (Pubitemid 19166673)
40. Association of beta3-adrenergic receptor gene polymorphism with insulin resistance in Japanese-American men. Kawamura T, Egusa G, Okubo M, Imazu M, Yamakido M, Metabolism 1999 48 1367 1370 10.1016/S0026-0495(99)90145-2 10582543 (Pubitemid 29536434)
41. The beta3-adrenergic receptor in the obesity and diabetes prone rhesus monkey is very similar to human and contains arginine at codon 64. Walston J, Lowe A, Silver K, Yang Y, Bodkin NL, Hansen BC, Shuldiner AR, Gene 1997 188 207 213 10.1016/S0378-1119(96)00796-2 9133593 (Pubitemid 27170995)
42. DNA methylation and human disease. Robertson K, Nat Rev Genet 2005 6 597 610 16136652 (Pubitemid 41044297)
43. Epigenetic regulation of gene expression: how the genome intergrates intrinsic and environmental signals. Jaenisch R, Bird A, Nat Genet 2003 33 245 254 10.1038/ng1089 12610534 (Pubitemid 36278835)
44. From genome to epigenome. Murrell A, Rakyan VK, Beck S, Hum Mol Genet 2005 1 3 R10
45. DNA methylation presents distinct binding sites for human transcription factors. Hu S, Wan J, Su Y, Song Q, Zeng Y, Nguyen HN, Shin J, Cox E, Rho HS, Woodard C, Xia S, Liu S, Lyu H, Ming GL, Wade H, Song H, Qian J, Zhu H, Elife 2013 3 2 00726
46. CpG methylation as a mechanism for the regulation of E2F activity. Campanero MR, Armstrong MI, Flemington EK, Proc Natl Acad Sci USA 2000 97 6481 6486 10.1073/pnas.100340697 10823896 (Pubitemid 30412739)
47. Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxia-inducible factor-1 DNA-binding site. Wenger RH, Kvietikova I, Rolfs A, Camenisch G, Gassmann M, Eur J Biochem 1998 253 771 777 10.1046/j.1432-1327.1998.2530771.x 9654078 (Pubitemid 28223547)
48. The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding. Mulero-Navarro S, Carvajal-Gonzalez JM, Herranz M, Ballestar E, Fraga MF, Ropero S, Esteller M, Fernandez-Salguero PM, Carcinogenesis 2006 27 1099 1104 10.1093/carcin/bgi344 16410262
49. Structure of the gene for human beta 2-adrenergic receptor: expression and promoter characterization. Emorine LJ, Marullo S, Delavier-Klutchko C, Kaveri SV, Durieu-Trautmann O, Strosberg AD, Proc Natl Acad Sci 1987 84 20 6995 6999 10.1073/pnas.84.20.6995 2823249 (Pubitemid 18017318)
50. Epigenetic modulation of the renal β-adrenergic-WNK4 pathway in salt-sensitive hypertension. Mu S, Shimosawa T, Ogura S, Wang H, Uetake Y, Kawakami-Mori F, Marumo T, Yatomi Y, Geller DS, Tanaka H, Fujita T, Nat Med 2011 17 573 580 10.1038/nm.2337 21499270
51. Association between beta3-adrenergic receptor and oxidative stress in chronic heart failure rats. Kong YH, Zhang Y, Li N, Zhang L, Gao YH, Xue HJ, Li Y, Li WM, Zhonghua Xin Xue Guan Bing Za Zhi 2010 38 5 435 439 20654104
52. Functional expression of beta2 adrenergic receptors responsible for protection against oxidative stress through promotion of glutathione synthesis after Nrf2 upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells. Takahata Y, Takarada T, Iemata M, Yamamoto T, Nakamura Y, Kodama A, Yoneda Y, J Cell Physiol 2009 218 2 268 275 10.1002/jcp.21594 18814142
53. Beta 3-adrenergic receptors regulate retinal endothelial cell migration and proliferation. Steinle JJ, Booz GW, Meininger CJ, Day JN, Granger HJ, J Biol Chem 2003 278 20681 20686 10.1074/jbc.M300368200 12670949 (Pubitemid 36806369)
54. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M, Chem Biol Interact 2006 160 1 1 40 10.1016/j.cbi.2005.12.009 16430879 (Pubitemid 43227479)
55. Role of oxygen radicals in DNA damage and cancer incidence. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J, Mol Cell Biochem 2004 266 1-2 37 56 15646026 (Pubitemid 39562306)
56. DNA methylation and the association between genetic and epigenetic changes: relation to carcinogenesis. Wachsman JT, Mutat Res 1997 375 1 1 8 10.1016/S0027-5107(97)00003-1 9129674 (Pubitemid 27152196)